After Catalyst Case, FDA Won't Stop Approving Orphan Drugs

By Adam Lidgett · January 23, 2023, 5:34 PM EST

The U.S. Food and Drug Administration has said a loss in litigation involving a treatment for a rare autoimmune disease won't stop it from approving new orphan drugs if they have...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login